Insulet slips on worse-than-expected Q2 loss and lowered full year guidance
Shares of Insulet Corp. (Nasdaq:PODD) are treading lower today after the patch pump technology maker reported after Tuesday’s close that its second-quarter loss narrowed from the same quarter a year ago, but still managed to miss the consensus on Wall Street. The firm also lowered full year guidance, citing a slower than anticipated conversion of referrals to patient shipments.
Shares slipped 9%, or $1.39, to $13.52 mid-morning. For detailed price information and news stories on Insulet, click PODD.
